Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium oxalate crystallization refers to the process by which calcium ions (Ca2+) and oxalate ions (C2O42-) combine to form insoluble calcium oxalate crystals. This process is significant in both biological and pathological contexts, most notably as the primary inorganic component of kidney stones in humans, but also as a common biomineral in plants. The process involves nucleation, growth, aggregation, and retention. Several factors influence the crystallization process, including supersaturation, pH, and urinary macromolecules. In humans, crystal retention depends on interactions between crystals and renal tubular epithelial cells.
Citrate inhibits calcium oxalate crystal formation by binding to crystal surfaces.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium Oxalate Crystallization (None).